Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences has applied for federal approval of a “next-generation” Cologuard test, meaning the new version of its stool-based test to screen for colon cancer could become available by 2025.
Exact Sciences Corp (EXAS) Announces 17% Revenue Increase and Provides Optimistic 2024 Outlook
MADISON, Wis. (AP) — MADISON, Wis. (AP) — Exact Sciences Corp. (EXAS) on Wednesday reported a loss of $49.8 million in its fourth quarter.
/PRNewswire/ -- The "Multi-Cancer Diagnostic Tests: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. Cancer is one of the...
180 Life Sciences Corp. (NASDAQ:ATNF – Get Free Report) saw a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 443,300 shares, a decline of 61.8% from the January 15th total of 1,160,000 shares. Based on an average trading volume of 1,170,000 shares, the days-to-cover […]